NO864782D0 - Fremgangsmaate ved fremstilling av kinolon-derivater. - Google Patents

Fremgangsmaate ved fremstilling av kinolon-derivater.

Info

Publication number
NO864782D0
NO864782D0 NO864782A NO864782A NO864782D0 NO 864782 D0 NO864782 D0 NO 864782D0 NO 864782 A NO864782 A NO 864782A NO 864782 A NO864782 A NO 864782A NO 864782 D0 NO864782 D0 NO 864782D0
Authority
NO
Norway
Prior art keywords
quinolon
derivatives
procedure
preparation
quinolon derivatives
Prior art date
Application number
NO864782A
Other languages
English (en)
Norwegian (no)
Inventor
Simon Fraser Campbell
David Anthony Roberts
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NO864782D0 publication Critical patent/NO864782D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO864782A 1985-11-28 1986-11-27 Fremgangsmaate ved fremstilling av kinolon-derivater. NO864782D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858529362A GB8529362D0 (en) 1985-11-28 1985-11-28 Quinolone cardiac stimulants

Publications (1)

Publication Number Publication Date
NO864782D0 true NO864782D0 (no) 1986-11-27

Family

ID=10588943

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864782A NO864782D0 (no) 1985-11-28 1986-11-27 Fremgangsmaate ved fremstilling av kinolon-derivater.

Country Status (20)

Country Link
US (1) US4740513A (pt)
EP (1) EP0226357A1 (pt)
JP (1) JPS62138490A (pt)
KR (1) KR890002795B1 (pt)
CN (1) CN1004205B (pt)
AU (1) AU569200B2 (pt)
DD (2) DD265403A5 (pt)
DK (1) DK570486A (pt)
FI (1) FI864814A (pt)
GB (1) GB8529362D0 (pt)
HU (1) HU196989B (pt)
IL (1) IL80799A0 (pt)
NO (1) NO864782D0 (pt)
NZ (1) NZ218428A (pt)
PH (1) PH23868A (pt)
PL (2) PL151696B1 (pt)
PT (1) PT83810B (pt)
SU (1) SU1470190A3 (pt)
YU (1) YU44603B (pt)
ZA (1) ZA868978B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
DE19636994A1 (de) * 1996-09-12 1998-03-19 Basf Ag Verfahren zur Herstellung von (2'-Fluorphenyl)-3-halogenpyridinen
JP2003525838A (ja) * 1997-09-24 2003-09-02 オリオン コーポレーション ホスホランバン阻害剤としての１−オキサ、アザおよびチアナフタレン−２−オンのビスエーテル類
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US8937184B2 (en) * 2005-02-16 2015-01-20 Abbvie B.V. 1H-imidazole derivatives as cannabinoid CB2 receptor modulators

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
JPS5473783A (en) * 1977-11-15 1979-06-13 Otsuka Pharmaceut Co Ltd Pyridine derivative
DE2815956A1 (de) * 1978-04-13 1979-10-18 Bayer Ag Verfahren zur herstellung von in 2-stellung substituierten triazolen-1,2,3
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
JPS5576872A (en) * 1978-12-06 1980-06-10 Yoshitomi Pharmaceut Ind Ltd Imidazolidinone derivative
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
EP0102046A1 (en) * 1982-08-26 1984-03-07 Schering Corporation Tricyclic lactams, method for making them, pharmaceutical compositions containing them
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4591591A (en) * 1984-03-08 1986-05-27 Eli Lilly And Company Pyridazinone derivatives as inotropic agents
US4721721A (en) * 1984-12-18 1988-01-26 Rorer Pharmaceutical Corporation 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses

Also Published As

Publication number Publication date
US4740513A (en) 1988-04-26
GB8529362D0 (en) 1986-01-02
YU44603B (en) 1990-10-31
CN1004205B (zh) 1989-05-17
HUT42082A (en) 1987-06-29
DK570486A (da) 1987-08-03
PH23868A (en) 1989-11-23
CN86108133A (zh) 1987-09-09
PT83810A (en) 1986-12-01
KR870004975A (ko) 1987-06-02
IL80799A0 (en) 1987-02-27
PT83810B (en) 1988-12-09
DD270710A5 (de) 1989-08-09
PL270983A1 (en) 1988-09-15
NZ218428A (en) 1989-03-29
KR890002795B1 (ko) 1989-07-31
PL262599A1 (en) 1988-07-07
ZA868978B (en) 1988-07-27
AU6575486A (en) 1987-06-11
FI864814A0 (fi) 1986-11-26
YU202686A (en) 1987-12-31
DD265403A5 (de) 1989-03-01
FI864814A (fi) 1987-05-29
SU1470190A3 (ru) 1989-03-30
JPS62138490A (ja) 1987-06-22
AU569200B2 (en) 1988-01-21
HU196989B (en) 1989-02-28
DK570486D0 (da) 1986-11-27
EP0226357A1 (en) 1987-06-24
PL151696B1 (en) 1990-09-28

Similar Documents

Publication Publication Date Title
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO880068L (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
NO165755C (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO855356L (no) Fremgangsmaate ved fremstilling av cefem-derivater.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO863251L (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO854655L (no) Fremgangsmaate ved fremstilling av flavolignanderivateer.
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO862233D0 (no) Fremgangsmaate ved fremstilling av imidazoquinazolinderivater.
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO166710C (no) Fremgangsmaate ved fremstilling av uretaner.
NO881055L (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.